Table 4.
Target for ≥90% national DTP3 coverage | Target for MNT elimination | Target to have a functional NITAG | Target to introduce at least one new or underutilized vaccineb | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Target not met | Target met |
p-
value |
Target not met | Target met |
p-
value |
Target not met | Target met |
p-
value |
Target not met | Target met |
p-
value |
|
n a =102 | n a =27 | n a = 71 | n a = 58 | n a = 105 | n a = 24 | n a = 103 | n a = 24 | |||||
PHE type | ||||||||||||
Armed conflict | ||||||||||||
Median | 1 | 0 | <0.01* | 1 | 0 | <0.01* | 0 | 0.5 | 0.40 | 1 | 0 | 0.05 |
[IQR] | [5] | [0] | [5.5] | [1] | [3] | [5] | [3] | [1] | ||||
Disaster | ||||||||||||
Median | 2 | 2 | 0.90 | 2 | 1 | 0.03* | 2 | 2 | 0.30 | 2 | 2 | 0.60 |
[IQR] | [2] | [2] | [2.5] | [2] | [2] | [1] | [2] | [2] | ||||
Disease outbreak | ||||||||||||
Median | 1 | 1 | 0.10 | 1 | 1 | 0.90 | 1 | 2 | 0.40 | 1 | 1 | 0.60 |
[IQR] | [2] | [1.5] | [2] | [2] | [2] | [3] | [2] | [1] | ||||
Total PHEsc | ||||||||||||
Median | 5 | 3 | <0.01* | 5 | 3 | <0.01* | 4 | 5 | 0.10 | 5 | 5 | 0.06 |
[IQR] | [6] | [2] | [7] | [3] | [5] | [6.5] | [3] | [3] |
p-value significant.
Between 2010 and 2019 each of the 13 countries contributed 10 years, except for South Sudan (gained independence in 2011), which contributed 9 years, hence, the total number of years for all the 13 countries was 129.
For this target 2 years had no data as two countries had already introduced all the three new vaccines examined in the study in their preceding years.
This variable is a function of the total count of the armed conflict, disaster, and disease outbreak variable.